MyAverix Finance
NS · Healthcare
Astal Laboratories Ltd (512600)
Pharmaceuticals & Biotechnology
Astal Laboratories Ltd (512600) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $3.23B, P/E ratio is 42.45, net margin is 7.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 512600
Astal Laboratories Ltd (512600) — FAQ
What is Astal Laboratories Ltd's market cap?
Astal Laboratories Ltd (512600) has a reported market cap of $3.23B (data as of 2026-07-10).
What is 512600's P/E ratio?
The price-to-earnings (P/E) ratio for Astal Laboratories Ltd (512600) is 42.45 (data as of 2026-07-10).
Does Astal Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Astal Laboratories Ltd (512600). Check the MyAverix Finance app for the latest dividend data.
What sector is Astal Laboratories Ltd in?
Astal Laboratories Ltd (512600) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 512600 listed on?
512600 is listed on NS.
What is Astal Laboratories Ltd's net margin?
Astal Laboratories Ltd (512600) reports a net margin of 7.5% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.